Our goal is to revolutionize bone regeneration for dental implants by developing superior bone graft substitute products with breakthrough technology and innovative procedure. The guiding light of the genesis of Wishbone is to design and fine-tune a high-tech recipe to extract and inactivate all proteins, including prions, from bovine bone, but which would preserve the highly osteoconductive micro and nano-topography of the natural bone. Wishbone biomaterials result from the collaboration between chemists, biomedical engineers and clinician experts in dental tissue engineering. Wishbone has invested in a high tech facility for R&D, production and QC, including a qualified ISO 7 cleanroom. The company is ISO 13485 certified.
| Website | https://www.wishbone-biotech.com |
| Employees | 10 (7 on RocketReach) |
| Founded | 2013 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Bone Regeneration, Dental Implants, Bone Graft Substitutes, Biomaterials, Regenerative Medicine, Dental Surgery, Oral Surgery, Maxillofacial Surgery, Tissue Engineering, Implant Dentistry, Periodontics, Osseointegration, Bone Healing, Biocompatible Materials, Surgical Materials, Medical Devices, Dental Technology, Pharmaceutical |
| Competitors | Agenus, Axovant Sciences Ltd, Amgen, Sangamo Therapeutics, Inc., bluebird bio, Allogene Therapeutics, Editas Medicine, Beam Therapeutics, CureVac, Zymeworks Inc. +47 more (view full list) |
Looking for a particular Wishbone Biotech employee's phone or email?
Emilie Dory is the CEO of Wishbone Biotech.
7 people are employed at Wishbone Biotech.